MEI Pharma, Inc. (MEIP)

Oncology Corporate Profile

Stock Performance

1.4400
0.0100

HQ Location

11975 El Camino Real, Suite 101
San Diego, CA 92130

Company Description

MEI Pharma (formerly Marshall Edwards Inc.) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. Our programs include a potential best-in-class HDAC inhibitor, Pracinostat, and two isoflavone-based drug candidates, ME-143 and ME-344.

Website: http://www.meipharma.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
pracinostat (+ azacitidine)HDAC inhibitor (oral)Acute Myelogenous Leukemia (AML)IIHelsinn
ME-344 (+ bevacizumab)mitochondrial inhibitorBreast cancer (HER2+)II
pracinostat (+ azacitidine)HDAC inhibitor (oral)Myelodysplastic Syndrome (MDS)II
pracinostat (+ ruxolitnib)HDAC inhibitor (oral)MyelofibrosisII
ME-401PI3K Delta InhibitorChronic Lymphocytic Leukemia (CLL)I
ME-401P13K delta inhibitorFollicular LymphomaI
ME-143NADH oxidase inhibitorVarious cancer typesI
phenoxodiolNADH oxidase inhibitorVarious cancer typesINovogen
PWT143P13K delta inhibitorVarious cancer typesPreclinical

View additional information on product candidates here »

Source: http://www.meipharma.com/

Recent News Headlines

5/22/2017 12:18 pm

5/22/2017 12:18 pm

5/22/2017 12:18 pm

5/22/2017 12:18 pm

5/22/2017 12:18 pm

5/22/2017 06:18 am

5/22/2017 06:18 am

5/22/2017 06:18 am

5/22/2017 06:18 am

5/22/2017 06:18 am

5/18/2017 06:18 am

5/18/2017 06:18 am

5/18/2017 06:18 am

5/18/2017 06:18 am

5/18/2017 06:18 am

5/4/2017 06:18 am

5/4/2017 06:18 am

5/4/2017 06:18 am

5/4/2017 06:18 am

MEI Pharma Announces Appointment of Brian Drazba as Chief Financial Officer

4/3/2017 12:00 pm

[PR Newswire] - SAN DIEGO, April 3, 2017 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced the appointment of Brian Drazba as Chief Financial Officer. Mr. Drazba joins the Company with more than 25 years of financial management experience in the healthcare industry, most recently as Chief Financial Officer of Heron Therapeutics, Inc., a commercial-stage biotechnology company.

MEI Pharma to Present at Needham Healthcare Conference

3/28/2017 01:00 pm

[PR Newswire] - SAN DIEGO, March 28, 2017 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the Needham Healthcare Conference on Tuesday, April 4, 2017 at 4:20 p.m. Eastern time from the Westin New York Grand Central. MEI Pharma, Inc. (MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.

MEI Pharma to Present at Oppenheimer Healthcare Conference

3/14/2017 01:00 pm

[PR Newswire] - SAN DIEGO, March 14, 2017 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer Healthcare Conference on Tuesday, March 21, 2017 at 9:10 a.m. Eastern time from the Westin New York Grand Central. MEI Pharma, Inc. (MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.

MEI PHARMA, INC. Financials

2/11/2017 06:00 pm